Want to see JP:4671 full AI Analyst Report?
4671 Stock Chart & Stats
¥2681.00
-¥4.00(-0.17%)
At close: 4:00 PM EST
¥2681.00
-¥4.00(-0.17%)
Day’s Range― - ―
52-Week Range¥2,438.00 - ¥2,848.00
Previous CloseN/A
Volume5.90K
Average Volume (3M)15.38K
Market Cap
¥27.86B
Enterprise Value¥18.12K
Total Cash (Recent Filing)¥8.68B
Total Debt (Recent Filing)¥1.02B
Price to Earnings (P/E)13.5
Beta0.57
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.44%
Share Statistics
EPS (TTM)208.04
Shares Outstanding10,680,177
10 Day Avg. Volume10,950
30 Day Avg. Volume15,383
Financial Highlights & Ratios
PEG Ratio1.23
Price to Book (P/B)1.01
Price to Sales (P/S)0.60
P/FCF Ratio17.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)182.7
Revenue Forecast (FY)¥43.60B
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageVery low and improving leverage gives FALCO substantial financial flexibility. The company is less dependent on borrowing, reducing solvency risk and preserving capacity to fund operations, investment, or shareholder returns through changing conditions.
Positive Cash GenerationConsistently positive operating and free cash flow indicates that the laboratory-services model generates internal funding. This supports ongoing operations and reduces reliance on external capital, even though conversion quality remains uneven.
Revenue ReaccelerationThe return to double-digit revenue growth suggests demand and business activity have regained momentum after the earlier contraction. Sustained growth would improve operating leverage and provide a stronger base for earnings recovery.
Bears Say
Margin CompressionAlthough profitability remains positive, lower operating and net margins indicate that earnings power is weaker than at the 2022 peak. Persistent compression could limit profit growth even if revenue continues recovering.
Uneven Free Cash Flow QualityPositive cash generation is tempered by weak conversion from accounting earnings and significant year-to-year volatility. This makes internally generated funds less predictable and could constrain the timing or scale of investment and distributions.
Recent Revenue HistoryThe recent recovery follows a multi-year period of contraction and only modest growth in 2025. That history indicates uncertainty over the durability of the latest acceleration and leaves the company exposed if demand or test volumes soften.
4671 FAQ
What was FALCO HOLDINGS Co., Ltd’s price range in the past 12 months?
FALCO HOLDINGS Co., Ltd lowest stock price was ¥2438.00 and its highest was ¥2848.00 in the past 12 months.
What is FALCO HOLDINGS Co., Ltd’s market cap?
FALCO HOLDINGS Co., Ltd’s market cap is ¥27.86B.
When is FALCO HOLDINGS Co., Ltd’s upcoming earnings report date?
FALCO HOLDINGS Co., Ltd’s upcoming earnings report date is Nov 10, 2026 which is in 84 days.
How were FALCO HOLDINGS Co., Ltd’s earnings last quarter?
FALCO HOLDINGS Co., Ltd released its earnings results on Aug 05, 2026. The company reported ¥38.58 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is FALCO HOLDINGS Co., Ltd overvalued?
According to Wall Street analysts FALCO HOLDINGS Co., Ltd’s price is currently Overvalued.
Does FALCO HOLDINGS Co., Ltd pay dividends?
FALCO HOLDINGS Co., Ltd pays a Semiannually dividend of ¥64 which represents an annual dividend yield of 4.44%. See more information on FALCO HOLDINGS Co., Ltd dividends here
What is FALCO HOLDINGS Co., Ltd’s EPS estimate?
FALCO HOLDINGS Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FALCO HOLDINGS Co., Ltd have?
FALCO HOLDINGS Co., Ltd has 10,680,177 shares outstanding.
What happened to FALCO HOLDINGS Co., Ltd’s price movement after its last earnings report?
FALCO HOLDINGS Co., Ltd reported an EPS of ¥38.58 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.346%.
Which hedge fund is a major shareholder of FALCO HOLDINGS Co., Ltd?
Currently, no hedge funds are holding shares in JP:4671
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
FALCO HOLDINGS Co., Ltd
FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.
Technical Analysis
AnGes
―
BML
―
Shin Nippon Biomedical Laboratories, Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
RaQualia Pharma Inc.
―